Why is Aarti Drugs falling/rising?

As of 23-Sep, Aarti Drugs Ltd is currently priced at 513.45, reflecting a decline of 6.9 points or 1.33%. The stock has been underperforming recently, having fallen consecutively for the last two days, resulting in a total decrease of 2.19%. Today's performance indicates that it has underperformed its sector by 0.98%. Despite being higher than the 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume decreasing by 38.58% compared to the 5-day average. Over the past month, the stock has shown a positive return of 6.13%, but it has underperformed over the longer term, with a 1-year return of -3.45%.
In the broader market context, Aarti Drugs has outperformed the Sensex over the past week, gaining 0.88% compared to the benchmark's decline of 0.34%. However, the stock's performance over the last three years is notably weaker, with a return of 9.82% compared to the Sensex's impressive 41.31%. Despite these challenges, the company maintains a high return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45, indicating solid management efficiency and financial stability. The stock is trading at a discount relative to its peers, and while it has generated a negative return over the past year, its profits have increased by 20.4%, suggesting potential for recovery.